جست‌وجوی استاد و پژوهشگر

Wojtek Pawlowskiمشاهده پروفایل

استاد

• Meiotic Recombination
• Plant Genetics
• Genome Architecture
• +۴ مورد دیگر

Wojtek Pawlowski serves as Professor at Cornell University's School of Integrative Plant Science, holding dual appointments in the Plant Biology Section and Plant Breeding and Genetics Section. His laboratory is housed in the Plant Science Building at Cornell's Ithaca campus, where he conducts cutting-edge research on meiotic processes in plants. Dr. Pawlowski's research focuses on three interconnected themes: (i) mapping and understanding meiotic recombination patterns in maize genomes, (ii) investigating chromosome dynamics during early meiotic prophase using advanced microscopy techniques including restorative deconvolution and structured illumination microscopy, and (iii) studying genome rearrangements in newly formed polyploids. His work bridges fundamental chromosome biology with practical plant breeding applications, particularly through NSF-sponsored research on increasing crossovers in recombination-depressed genomic regions. Analysis of his publication record reveals consistent focus on maize as a model system, with significant contributions to understanding double-strand break formation, crossover distribution mechanisms, and chromatin features influencing recombination outcomes. His most recent work extends into commercial applications through Meiogenix, a chromosome-editing startup advancing non-GMO plant breeding solutions. Dr. Pawlowski actively contributes to education and outreach through courses in genetics and evolution, including Plant Evolutionary Biology (PLSCI 3440), and co-directs the NSF-sponsored SUMMIT program providing research internships for minority undergraduate students. His laboratory collaborates internationally through ERA-CAPS/NSF initiatives focused on chromosome axis dynamics.

• Hematology
• Oncology
• Lymphoma
• +۴ مورد دیگر

Andres José Maria Ferreri is a Full Professor of Medicine at Università Vita-Salute San Raffaele in the Faculty of Medicine and Surgery. His academic work focuses on blood diseases, particularly hematology and oncology, with specialization in lymphoma and leukemia. Dr. Ferreri's research interests center on blood diseases, with particular emphasis on lymphoma subtypes (especially central nervous system lymphoma and Burkitt lymphoma), hematopoietic cell transplantation, and the intersection of HIV and hematological malignancies. His work combines clinical research with translational approaches, investigating novel therapeutic strategies and diagnostic methods for blood cancers. He has made significant contributions to understanding the molecular mechanisms of lymphoma and developing improved treatment protocols for various lymphoma subtypes. His extensive publication record includes over 345 articles, with recent work showing a strong trend toward personalized medicine approaches, incorporating molecular diagnostics like liquid biopsy techniques and novel therapeutic strategies for blood cancers. His research spans clinical trials, systematic reviews, molecular diagnostics, and translational studies focused on improving outcomes for lymphoma patients. Member of the Editorial Board for BLOOD journal (2021-present) Scientific Director for the European Federation for Immunogenetics (EFI) (2021-present) Advisory Board Member for the Center for International Blood and Marrow Transplant Research (CIBMTR) (2021-present) Scientific Committee Member for the American Society of Hematology (ASH) (2020-present) As an educator, Dr. Ferreri teaches Hematology courses for the Master's Degree in Medicine and Surgery program, as well as courses on Blood and Immune System Diseases. His research team focuses on translational hematology research with particular emphasis on lymphoma biology, novel therapeutic approaches, and improving outcomes for patients with blood cancers. His future work appears directed toward integrating molecular diagnostics with personalized treatment approaches for lymphoma patients.

Mariusz Nowackiمشاهده پروفایل

استاد

• Epigenetic mechanisms
• RNA-mediated epigenetic inheritance
• Genome editing
• +۶ مورد دیگر

Prof. Dr. Mariusz Nowacki is a Full Professor of Genetics and Director of the Institute of Cell Biology at the University of Bern, Switzerland. His research focuses on RNA-mediated epigenetic inheritance in eukaryotic cells, particularly using ciliated protozoa as model organisms to study whole-genome scale developmental DNA rearrangements. His lab investigates how parental cells provide sufficient information to produce fully functional progeny through RNA-mediated comparison of developing zygotic genomes with maternal somatic genomes. Nowacki's research interests center on epigenetic mechanisms of complex genome editing in eukaryotes, with particular focus on RNA-mediated epigenetic inheritance, developmental DNA rearrangements, and chromatin remodeling. His work examines how ciliates execute precise genome rearrangements during sexual reproduction, including elimination of transposons and internal eliminated sequences (IESs), which results in streamlined gene-rich genomes. His lab has made significant contributions to understanding the scan RNA model and RNA-guided genome rearrangement processes. His recent publications reveal trends in RNA biology, epigenetic inheritance, and genome architecture, with particular emphasis on small RNA pathways, chromatin remodeling complexes, and the molecular mechanisms underlying programmed DNA elimination. His work bridges molecular biology, genetics, and evolutionary biology, providing insights into fundamental cellular processes conserved across eukaryotes. ERC Starting Grant (2010) ERC Consolidator Grant (2016) Prof. Nowacki leads a research group comprising multiple PhD students, postdocs, and research staff, focusing on various aspects of ciliate genome biology. His lab is part of the national research excellence network NCCR RNA and Disease. His team investigates both basic mechanisms of genome rearrangement and potential applications of these processes to broader biological questions. Current projects include studying the roles of SMC proteins in DNA elimination, chromatin remodeling in sRNA-guided DNA elimination, and the identification of novel long non-coding RNAs involved in programmed genome rearrangements. The Nowacki Lab operates within the Institute of Cell Biology at the University of Bern, utilizing ciliates such as Paramecium and Oxytricha as model systems. Their research combines molecular, genetic, and biochemical approaches to unravel the complex mechanisms of RNA-mediated epigenetic inheritance and genome rearrangement.

Joana Isabel Meierمشاهده پروفایل

پژوهشگر ارشد

• Evolutionary Biology
• Genomics
• Speciation
• +۷ مورد دیگر

Dr. Joana Isabel Meier is a Royal Society University Research Fellow and Group Leader at the Tree of Life Programme of the Wellcome Sanger Institute. She holds a joint affiliation with the Department of Zoology , University of Cambridge, and previously served as a Branco Weiss Fellow and Bateson Research Fellow at St John’s College, University of Cambridge. Her work focuses on evolutionary genomics, particularly the mechanisms driving rapid speciation and adaptation across diverse taxa. Education: Bachelor of Science in Biology (insigni cum laude) , University of Bern Master of Science in Ecology and Evolution (summa cum laude) , University of Bern PhD in Ecology and Evolution (summa cum laude) , University of Bern Semester abroad, University of Vermont Research Interests: Dr. Meier investigates the genomic underpinnings of rapid speciation and adaptive radiation, emphasizing the roles of hybridization, chromosomal rearrangements, and genetic architecture. Her team studies diverse organisms including ithomiini butterflies, peacock spiders, and cichlid fishes, leveraging whole-genome sequencing to uncover how lineages diversify at accelerated rates. Key questions include the interplay between ecological opportunity and genetic exchange in adaptive radiations. Scientific Awards: Royal Society University Research Fellowship Branco Weiss Fellowship Bateson Research Fellowship Collaborations: Dr. Meier collaborates extensively across institutions, including the University of Berkeley, University of Sydney, and research teams in Ecuador, Colombia, and Brazil. She contributes to large-scale initiatives like the Darwin Tree of Life Project and leads Project Psyche for sequencing European Lepidoptera.

Adam Ameurمشاهده پروفایل

دانشیار

• Long-read Sequencing
• Clinical Genomics
• Human Genomics
• +۶ مورد دیگر

Adam Ameur is an Associate Professor in Genomics and Bioinformatics at Uppsala University, affiliated with SciLifeLab. His work develops genomic technologies and infrastructure to advance human genome understanding and disease diagnostics, with expertise in long-read sequencing applications for medical genetics. He leads Sweden's national reference genome project and co-founded the Precision Omics Initiative Sweden (PROMISE). His research spans: Long-read Sequencing Clinical Genomics Human Genomics Bioinformatics Transcriptomics Medical Genetics Specializing in structural variant analysis, tandem repeat characterization, and genomic data integration for clinical translation. Recent publications (2024-2025) emphasize long-read sequencing in population-scale chromosomal rearrangement studies, nanopore-based tandem repeat analysis (pathSTR), and multiomic cancer characterization. A unifying theme is healthcare integration, exemplified by PROMISE's framework for connecting genomic research with clinical practice in Sweden. He directs the Swedish reference genome initiative and co-leads PROMISE, operating through SciLifeLab's national infrastructure for molecular biosciences.

• Bioinformatics
• Computational Biology
• Genomics
• +۳ مورد دیگر

Mr. Leonard Bohnenkämper, M.Sc., is a researcher affiliated with the Faculty of Engineering at Bielefeld University . He is actively involved with the Genome Informatics Group and the Center for Biotechnology (CeBiTec) , focusing on computational genomics and genome rearrangement analysis. His work spans algorithm development for genomic distance metrics and natural genome halving. His research interests include: Computational modeling of genome rearrangements Development of algorithms for natural genome analysis Genomic distance metrics and epidemiology applications Bioinformatics tool creation for large-scale genomic datasets Mr. Bohnenkämper contributes to academic infrastructure through his membership in the Institute for Bioinformatics Infrastructure (BIBI) board and management. His work aligns with Bielefeld University's strategic focus on socio-technical systems and interdisciplinary research at the intersection of computer science, biology, and technology. He is involved in: IT support for research groups Academic infrastructure development Training and education in bioinformatics

Christophe Dufresnesمشاهده پروفایل

دانشیار

• Herpetology
• Evolutionary Biology
• Biogeography
• +۵ مورد دیگر

Christophe Dufresnes serves as Associate Professor and Curator of Amphibians at the National Museum of Natural History (MNHN) in Paris, France. He manages the Amphibian collection and is affiliated with the SPEC research unit (Systematics, Phylogeography, Evolution, Conservation). He actively participates in scientific commissions of the French Herpetological Society (SHF) and the Societas Europaea Herpetologica (SEH). His research centers on herpetofauna evolution, biogeography, and conservation. Key interests include speciation mechanisms, sex determination evolution, and human-mediated biological invasions. Fieldwork and molecular analyses focus on Eurasian amphibians (anurans and urodeles), combining museum specimens with genomic approaches to address diversification and conservation challenges. Recent publications (2025) reveal a cohesive focus on amphibian systematics and conservation genetics. Studies span taxonomic revisions (e.g., Himalayan toads, Balkan yellow-bellied toads), invasion biology (e.g., marsh frog, black-spined toad), and genomic investigations of sex determination in toads. This integrated methodology bridges evolutionary theory with urgent conservation applications across Europe and Asia. Dufresnes leads the SPEC research unit, which drives interdisciplinary studies in systematics and conservation. He also contributes to public science through naturalist books on herpetofauna and active roles in SHF and SEH commissions, supporting European herpetological research and conservation policy.

Layla Oesperمشاهده پروفایل

دانشیار

• Computational Biology
• Cancer Genomics
• Algorithms
• +۱ مورد دیگر

Layla Oesper is an Associate Professor in the Computer Science Department at Carleton College. She previously worked as a post-doctoral researcher and graduate student at Brown University, where she earned her PhD and ScM in Computer Science. She received her BA in Mathematics from Pomona College and worked at Epic as a software tester. PhD in Computer Science - Brown University ScM in Computer Science - Brown University BA in Mathematics - Pomona College Her research focuses on designing algorithms for high-throughput DNA sequencing data analysis, particularly in cancer genomics. She develops computational methods for tumor evolutionary history inference, with emphasis on consensus approaches and noise tolerance in phylogenetic reconstruction. Recent publications highlight her work on computational biology education, distance measures for tumor phylogenies, and weighted consensus tree algorithms. Her research spans algorithm design, cancer genomics, and bioinformatics software development. NSF CAREER grant recipient (2021) Google Anita Borg Memorial Scholarship (2014) NSF Graduate Research Fellowship (2011) Best Presentation Award at HitSeq workshop (2014) She has advised multiple students who have received recognition in computational biology, including CRA Outstanding Undergraduate Researcher honorable mentions. Her software tools include TuELiP, CASet/DISC, and GraPhyC for tumor evolution analysis.

Jennifer Totonchyمشاهده پروفایل

دانشیار

• Immunology
• Virology
• Molecular Biology
• +۴ مورد دیگر

Dr. Jennifer Totonchy is an Associate Professor at Chapman University School of Pharmacy, specializing in Immunology and Virology . Her research focuses on Kaposi Sarcoma Herpesvirus (KSHV) infection mechanisms in human tonsil lymphocytes and synovial macrophage polarization in inflammatory joint diseases. Her work combines Molecular Biology of viral entry and host signaling Flow Cytometry for immune cell phenotyping Pharmacological studies on PRG4's anti-inflammatory effects to develop immunotherapeutic paradigms. Recent publications highlight her contributions to understanding KSHV tegument proteins in B lymphocyte infection and PRG4 regulation of synovial fibrosis. She has received the National Institute of Dental and Craniofacial Research K99/R00 award and maintains active collaborations across multiple institutions. Scientific awards include K99/R00 Pathway to Independence Award (2014) Her laboratory investigates viral-host interactions and synovial immunopathology , with applications in oncology and rheumatology.

Iman Hajirasoulihaمشاهده پروفایل

دانشیار

• Computational Biology
• Genomics
• Structural Variation Analysis
• +۶ مورد دیگر

Dr. Iman Hajirasouliha serves as Associate Professor of Systems and Computational Biomedicine at Weill Cornell Medical College since 2025. With a strong background in computational biology and genomics, they lead research at the intersection of bioinformatics, machine learning, and clinical medicine. Ph.D. in Computational Biology, Simon Fraser University (2012) M.Sc. in Computer Science, Simon Fraser University (2007) B.Sc. in Computer Engineering, Sharif University (2005) Their research focuses on three major areas: 1) Computational genomics for structural variation analysis and tumor phylogeny reconstruction, 2) Machine learning applications in reproductive medicine and embryo assessment, and 3) Metagenomic analysis of microbial communities and antibiotic resistance. They have developed innovative algorithms like Blackbird, Cue, and cloudrnaSPAdes for genomic data analysis. Recent publications highlight their work on spatial isoform sequencing in brain development, AI-based embryo ploidy prediction systems, and multi-omics analysis of disease states. Their research portfolio includes NIH-funded projects in computational biology and collaborations with the National Cancer Institute. Dr. Hajirasouliha's lab integrates computational methods with clinical applications, particularly in oncology and fertility medicine. They contribute to the development of the Tri-Institutional PhD Program in Computational Biology & Medicine and maintain active research collaborations across multiple institutions.

John Maciejowskiمشاهده پروفایل

پژوهشگر

• Genome Instability
• Telomere Biology
• Cancer Genomics
• +۵ مورد دیگر

Dr. John Maciejowski is a leading molecular biologist at Memorial Sloan Kettering Cancer Center (MSKCC) and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. His research focuses on understanding how nuclear envelope rupture contributes to genome instability in cancer, particularly through mechanisms like chromothripsis and kataegis during telomere crisis. PhD in Biomedical Sciences from MSKCC Current lab at MSKCC investigates TREX1 and APOBEC3B roles in DNA repair Uses cell biology, biochemistry, and genomics approaches His work has significant implications for cancer genome architecture and mutation patterns. Key publications include mechanistic studies on TREX1's role in micronuclei repair and APOBEC3B's contribution to mutagenesis. Scientific honors include: NIH Pathway to Independence Award (2016) Tri-Institutional Breakout Prize (2016) Regeneron Prize for Creative Innovation (2016) Pew Biomedical Scholar Current research explores connections between telomere dysfunction, DNA repair pathways, and immune system interactions with genomic DNA, supported by multiple NIH grants including R00 CA212290 and R35 CA210036.

Andrew Michael Intlekoferمشاهده پروفایل

استادیار

• Oncology
• Immunology
• Metabolic Disorders
• +۷ مورد دیگر

Andrew Michael Intlekofer is an Assistant Professor of Medicine at Weill Cornell Medical College since 2017. His work bridges oncology, immunology, and metabolic research, focusing on hematologic malignancies and tumor-immune interactions. Education: M.D., University of Pennsylvania School of Medicine (2009) Ph.D., University of Pennsylvania (2007) B.S., University of Maryland (2001) His research explores metabolic reprogramming in cancer cells , epigenetic dysregulation in leukemia/lymphoma , and immunotherapy mechanisms , particularly involving T cell metabolism. He has contributed to clinical trials in lymphoma and Hodgkin lymphoma. The 15 most recent publications (2025–2021) span oncology , immunology , and molecular biology , with recurring themes in B-cell lymphomas , T cell metabolic flexibility , epigenetic modifiers , and oncometabolites . Key subfields include targeted therapy resistance , immune checkpoint inhibition , mitochondrial dysfunction in tumors , and genomic profiling for precision oncology . His work often integrates clinical data and preclinical models to address therapeutic challenges.

Ekta Khuranaمشاهده پروفایل

دانشیار

• Computational Biology
• Cancer Genomics
• Chromatin Structure
• +۴ مورد دیگر

Ekta Khurana is an Associate Professor at Systems and Computational Biomedicine , Weill Cornell Medical College, with a focus on computational methods to identify non-coding cancer drivers, chromatin architecture, and integrative genomics. Her work bridges machine learning with cancer biology to uncover regulatory mechanisms and therapeutic targets. Education Ph.D., University of Pennsylvania (2008) M.Sc., Indian Institute of Technology (2002) B.Sc., University of Delhi (2000) Research Interests center on non-coding variants in cancer, 3D chromatin conformation, lineage plasticity, and regulatory network modeling. She pioneers tools like FunSeq2 and RegNetDriver to prioritize functional mutations in cancer genomes. Recent Articles (2023–2025) highlight her contributions to understanding TAD hierarchy disruptions, chromatin accessibility in prostate cancer, and machine learning applications for 3D genome analysis. Keywords: cancer driver discovery, non-coding mutations, chromatin structure, regulatory networks. Awards WorldQuant Foundation Research Scholar (2025) Grants include NCI-funded projects on non-coding oncogenic regions (2024–2029), Starr Cancer Consortium support for prostate cancer lineage plasticity (2024–2026), and NINDS funding for glioblastoma regulatory nodes (2024–2029).

Vanja Bugarski-Stanojevićمشاهده پروفایل

پژوهشگر

• Biodiversity and Conservation
• Molecular Phylogeny
• Cryptic Speciation
• +۸ مورد دیگر

Dr. Vanja Bugarski-Stanojević is a Senior Research Associate at the Department of Genetic Research, Institute for Biological Research "Siniša Stanković", University of Belgrade. She has been employed at the institute since December 3rd, 2004, conducting extensive research on subterranean mammals, particularly the European blind mole rat species complex (Nannospalax leucodon). Her work integrates cytogenetic, molecular, and morphological approaches to study evolutionary processes and biodiversity. Dr. Bugarski-Stanojević earned her B.S. in Biology from the University of Belgrade in 2003 and completed her Ph.D. in Genetics at the same institution in 2010 with a dissertation titled "Molecular phylogeny of species of the genus Apodemus (Mammalia, Rodentia) from Serbia." Her research focuses on biodiversity conservation, cryptic speciation, karyotype evolution, and the role of chromosomal rearrangements in speciation. She has developed non-invasive molecular genetic methods for differentiating morphologically similar species and detecting cryptic species. A significant portion of her work examines the European blind mole rat as a non-conventional model organism for studying cancer resistance, longevity, and regeneration. She also investigates supernumerary chromosomes in yellow-necked mice (Apodemus flavicollis), exploring their structure, transcriptional activity, origin, effects, and inheritance patterns. Dr. Bugarski-Stanojević's publication record demonstrates consistent research output focused on subterranean mammals, particularly blind mole rats, with emphasis on cryptic speciation, phylogeography, and conservation implications. Her recent work has expanded to include environmental DNA techniques for biodiversity monitoring. She serves on the editorial board of Frontiers in Genetics (since 2022) and previously served on Molecular Cytogenetics (2017-2022). In 2020-2022, she was Principal Investigator for a bilateral project between Serbia and France titled "Nematostella vectensis (Actinaria, Anthozoa) as a model for the investigation of Usher proteins." She has collaborated with the Institute of Human Genetics at Friedrich Schiller University Jena through DAAD-sponsored projects. Dr. Bugarski-Stanojević is actively involved in mentoring graduate, undergraduate, and PhD students. Her professional affiliations include the Serbian Biological Society, Serbian Genetic Society, and International Society of Zoological Sciences.

• Lymphoma
• CAR-T Cell Therapy
• Hematology
• +۵ مورد دیگر

Stephen J. Schuster, MD is a Professor of Medicine at the University of Pennsylvania's Perelman School of Medicine, where he serves as Director of the Lymphoma Program and Director of the Lymphoma Translational Research Program at the Abramson Cancer Center. He holds the distinguished position of Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma, reflecting his specialized expertise in this field. Dr. Schuster maintains clinical privileges at the Hospital of the University of Pennsylvania and is on the medical staff at Penn Presbyterian Medical Center. Dr. Schuster's research focuses on advancing lymphoma treatment through innovative approaches, particularly in CAR-T cell therapy and translational research. His work has significantly contributed to establishing CAR-T cell therapy as a standard treatment option for relapsed or refractory lymphomas. He leads multiple clinical trials evaluating novel therapies and combination approaches for B-cell malignancies, with particular emphasis on understanding mechanisms of treatment resistance and developing predictive biomarkers. Analysis of Dr. Schuster's recent publications (2021-2025) reveals a strong focus on optimizing CAR-T cell therapy for lymphoma patients, with significant contributions to understanding long-term outcomes, mechanisms of resistance, and strategies to improve treatment efficacy. His work spans both clinical trials and translational research, bridging laboratory findings with patient care. Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Multiple high-impact publications in journals including New England Journal of Medicine, Lancet, and Blood Principal investigator for pivotal CAR-T cell therapy trials (JULIET, ELARA) Dr. Schuster maintains an active clinical practice seeing patients aged 15-65 at the Abramson Cancer Center, with a patient satisfaction rating of 5.0 based on over 600 reviews. His clinical expertise complements his research leadership, allowing him to translate scientific discoveries into improved patient care for those with lymphoma and related hematologic malignancies.